1.
R script and aggregated data.
2.
3.
4.
The exposure-notification-action cascade during the SARS-CoV-2 epidemic in the Netherlands, 2020–2021.
5.
6.
7.
8.
9.
Reasons for testing over calendar time in the PHS Amsterdam, first RDT, and second RDT datasets in the Netherlands, 2020–2021.
Reasons for testing in the PHS Amsterdam, first RDT, and second RDT studies in the Netherlands, 2020–2021.
Results of Weibull regression models for the interval between last exposure and testing in days–PHS Amsterdam MCT subset.
Results of Weibull regression models for the interval between last exposure and testing in days–first RDT study.
Results of Weibull regression models for the interval between last exposure and testing in days–second RDT study.
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.
Overview of input parameters in MINTRISK.
Overview of the intermediate results for each input step and results for each output parameter of MINTRISK.
